atorvastatin has been researched along with Emergencies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Liu, Q; Wang, Y | 1 |
| Asrar Ul Haq, M; Mutha, V; Rudd, N; Subiakto, I; Van Gaal, WJ | 1 |
| Qu, Y; Wei, L; Zhang, H | 1 |
2 trial(s) available for atorvastatin and Emergencies
| Article | Year |
|---|---|
Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarc
Topics: Anti-Arrhythmia Agents; Atorvastatin; Benzazepines; Biomarkers; Clinical Protocols; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Emergencies; Femoral Neck Fractures; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Middle Aged; Myocardial Infarction; Orthopedic Procedures; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrroles; Research Design; Risk Factors; Severity of Illness Index; Tachycardia, Ventricular; Tomography, X-Ray Computed; Treatment Outcome; Victoria | 2014 |
Inhibition of inflammation mediates the protective effect of atorvastatin reload in patients with coronary artery disease undergoing noncardiac emergency surgery.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Chi-Square Distribution; China; Coronary Artery Disease; Disease-Free Survival; Drug Administration Schedule; Emergencies; Female; Heart Failure; Hospitalization; Humans; Incidence; Inflammation Mediators; Interleukin-6; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prospective Studies; Risk Factors; Single-Blind Method; Surgical Procedures, Operative; Time Factors; Treatment Outcome | 2014 |
1 other study(ies) available for atorvastatin and Emergencies
| Article | Year |
|---|---|
The functional effect of atorvastatin dose-dependent via inflammation factors on acute ST segment elevation myocardial infarction after emergency percutaneous coronary intervention.
Topics: Adult; Aged; Anti-Inflammatory Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Dose-Response Relationship, Drug; Emergencies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Male; Middle Aged; Percutaneous Coronary Intervention; Quality of Life; Recurrence; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome | 2019 |